Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: Decreased p 16 expression correlates with promoter methylation and poor prognosis

Ken Ichi Kawaguchi, Yoshinao Oda, Tsuyoshi Saito, Hidetaka Yamamoto, Sadafumi Tamiya, Tomonari Takahira, Kimitaka Miyajima, Yukihide Iwamoto, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The p16INK4a tumour suppressor gene, encoding p16 protein, plays a crucial role in regulation of the G1 cell-cycle phase. To investigate the potential role of p16 in soft tissue leiomyosarcoma (LMS), an immunohistochemical analysis was performed of 77 LMSs for p16 expression. Decreased expression of the p16 protein was identified in 25 of 77 LMSs (32%). Decreased expression of p16 correlated significantly with large tumour size (p = 0.0038). In a univariate analysis, large tumour size and decreased expression of p16 were statistically significant adverse prognostic factors (p = 0.025 and p = 0.0021, respectively). In a multivariate analysis including conventional clinicopathological parameters, decreased expression of p16 protein was revealed as the only independent unfavourable prognostic factor (p = 0.012). To elucidate the mechanisms of inactivation of the p16INK4a gene, 49 LMSs for which genomic DNA was available were examined; analysis for homozygous deletion, mutation, and promoter hypermethylation was conducted using differential PCR, PCR-SSCP, and methylation-specific PCR, respectively. Promoter hypermethylation was detected in 11 of 49 LMS cases (22%); homozygous deletion was detected in 3 of 49 cases (6%); and mutation was not recognized in any of the cases studied. Eight of 15 cases (53%) with decreased expression of p16 protein revealed methylation of the p16INK4a gene promoter. Promoter hypermethylation correlated closely with decreased expression and poor prognosis (p = 0.0014 and p = 0.0088, respectively). These results suggest that decreased expression of p16 protein can be considered as an independent reliable prognostic parameter in patients with soft tissue LMS. Furthermore, promoter methylation was more frequent than either homozygous deletion or mutation in this tumour, and promoter methylation was also shown to have a strong association with inactivation of the p16INK4a gene.

Original languageEnglish
Pages (from-to)487-495
Number of pages9
JournalJournal of Pathology
Volume201
Issue number3
DOIs
Publication statusPublished - Nov 1 2003

Fingerprint

p16 Genes
Leiomyosarcoma
Methylation
Sequence Deletion
Proteins
Polymerase Chain Reaction
Single-Stranded Conformational Polymorphism
Tumor Suppressor Genes
Carcinogens
Neoplasms
Cell Cycle
Multivariate Analysis
Mutation
DNA

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue : Decreased p 16 expression correlates with promoter methylation and poor prognosis. / Kawaguchi, Ken Ichi; Oda, Yoshinao; Saito, Tsuyoshi; Yamamoto, Hidetaka; Tamiya, Sadafumi; Takahira, Tomonari; Miyajima, Kimitaka; Iwamoto, Yukihide; Tsuneyoshi, Masazumi.

In: Journal of Pathology, Vol. 201, No. 3, 01.11.2003, p. 487-495.

Research output: Contribution to journalArticle

Kawaguchi, Ken Ichi ; Oda, Yoshinao ; Saito, Tsuyoshi ; Yamamoto, Hidetaka ; Tamiya, Sadafumi ; Takahira, Tomonari ; Miyajima, Kimitaka ; Iwamoto, Yukihide ; Tsuneyoshi, Masazumi. / Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue : Decreased p 16 expression correlates with promoter methylation and poor prognosis. In: Journal of Pathology. 2003 ; Vol. 201, No. 3. pp. 487-495.
@article{7831039422884f678a6eeea9af69c6ce,
title = "Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: Decreased p 16 expression correlates with promoter methylation and poor prognosis",
abstract = "The p16INK4a tumour suppressor gene, encoding p16 protein, plays a crucial role in regulation of the G1 cell-cycle phase. To investigate the potential role of p16 in soft tissue leiomyosarcoma (LMS), an immunohistochemical analysis was performed of 77 LMSs for p16 expression. Decreased expression of the p16 protein was identified in 25 of 77 LMSs (32{\%}). Decreased expression of p16 correlated significantly with large tumour size (p = 0.0038). In a univariate analysis, large tumour size and decreased expression of p16 were statistically significant adverse prognostic factors (p = 0.025 and p = 0.0021, respectively). In a multivariate analysis including conventional clinicopathological parameters, decreased expression of p16 protein was revealed as the only independent unfavourable prognostic factor (p = 0.012). To elucidate the mechanisms of inactivation of the p16INK4a gene, 49 LMSs for which genomic DNA was available were examined; analysis for homozygous deletion, mutation, and promoter hypermethylation was conducted using differential PCR, PCR-SSCP, and methylation-specific PCR, respectively. Promoter hypermethylation was detected in 11 of 49 LMS cases (22{\%}); homozygous deletion was detected in 3 of 49 cases (6{\%}); and mutation was not recognized in any of the cases studied. Eight of 15 cases (53{\%}) with decreased expression of p16 protein revealed methylation of the p16INK4a gene promoter. Promoter hypermethylation correlated closely with decreased expression and poor prognosis (p = 0.0014 and p = 0.0088, respectively). These results suggest that decreased expression of p16 protein can be considered as an independent reliable prognostic parameter in patients with soft tissue LMS. Furthermore, promoter methylation was more frequent than either homozygous deletion or mutation in this tumour, and promoter methylation was also shown to have a strong association with inactivation of the p16INK4a gene.",
author = "Kawaguchi, {Ken Ichi} and Yoshinao Oda and Tsuyoshi Saito and Hidetaka Yamamoto and Sadafumi Tamiya and Tomonari Takahira and Kimitaka Miyajima and Yukihide Iwamoto and Masazumi Tsuneyoshi",
year = "2003",
month = "11",
day = "1",
doi = "10.1002/path.1419",
language = "English",
volume = "201",
pages = "487--495",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue

T2 - Decreased p 16 expression correlates with promoter methylation and poor prognosis

AU - Kawaguchi, Ken Ichi

AU - Oda, Yoshinao

AU - Saito, Tsuyoshi

AU - Yamamoto, Hidetaka

AU - Tamiya, Sadafumi

AU - Takahira, Tomonari

AU - Miyajima, Kimitaka

AU - Iwamoto, Yukihide

AU - Tsuneyoshi, Masazumi

PY - 2003/11/1

Y1 - 2003/11/1

N2 - The p16INK4a tumour suppressor gene, encoding p16 protein, plays a crucial role in regulation of the G1 cell-cycle phase. To investigate the potential role of p16 in soft tissue leiomyosarcoma (LMS), an immunohistochemical analysis was performed of 77 LMSs for p16 expression. Decreased expression of the p16 protein was identified in 25 of 77 LMSs (32%). Decreased expression of p16 correlated significantly with large tumour size (p = 0.0038). In a univariate analysis, large tumour size and decreased expression of p16 were statistically significant adverse prognostic factors (p = 0.025 and p = 0.0021, respectively). In a multivariate analysis including conventional clinicopathological parameters, decreased expression of p16 protein was revealed as the only independent unfavourable prognostic factor (p = 0.012). To elucidate the mechanisms of inactivation of the p16INK4a gene, 49 LMSs for which genomic DNA was available were examined; analysis for homozygous deletion, mutation, and promoter hypermethylation was conducted using differential PCR, PCR-SSCP, and methylation-specific PCR, respectively. Promoter hypermethylation was detected in 11 of 49 LMS cases (22%); homozygous deletion was detected in 3 of 49 cases (6%); and mutation was not recognized in any of the cases studied. Eight of 15 cases (53%) with decreased expression of p16 protein revealed methylation of the p16INK4a gene promoter. Promoter hypermethylation correlated closely with decreased expression and poor prognosis (p = 0.0014 and p = 0.0088, respectively). These results suggest that decreased expression of p16 protein can be considered as an independent reliable prognostic parameter in patients with soft tissue LMS. Furthermore, promoter methylation was more frequent than either homozygous deletion or mutation in this tumour, and promoter methylation was also shown to have a strong association with inactivation of the p16INK4a gene.

AB - The p16INK4a tumour suppressor gene, encoding p16 protein, plays a crucial role in regulation of the G1 cell-cycle phase. To investigate the potential role of p16 in soft tissue leiomyosarcoma (LMS), an immunohistochemical analysis was performed of 77 LMSs for p16 expression. Decreased expression of the p16 protein was identified in 25 of 77 LMSs (32%). Decreased expression of p16 correlated significantly with large tumour size (p = 0.0038). In a univariate analysis, large tumour size and decreased expression of p16 were statistically significant adverse prognostic factors (p = 0.025 and p = 0.0021, respectively). In a multivariate analysis including conventional clinicopathological parameters, decreased expression of p16 protein was revealed as the only independent unfavourable prognostic factor (p = 0.012). To elucidate the mechanisms of inactivation of the p16INK4a gene, 49 LMSs for which genomic DNA was available were examined; analysis for homozygous deletion, mutation, and promoter hypermethylation was conducted using differential PCR, PCR-SSCP, and methylation-specific PCR, respectively. Promoter hypermethylation was detected in 11 of 49 LMS cases (22%); homozygous deletion was detected in 3 of 49 cases (6%); and mutation was not recognized in any of the cases studied. Eight of 15 cases (53%) with decreased expression of p16 protein revealed methylation of the p16INK4a gene promoter. Promoter hypermethylation correlated closely with decreased expression and poor prognosis (p = 0.0014 and p = 0.0088, respectively). These results suggest that decreased expression of p16 protein can be considered as an independent reliable prognostic parameter in patients with soft tissue LMS. Furthermore, promoter methylation was more frequent than either homozygous deletion or mutation in this tumour, and promoter methylation was also shown to have a strong association with inactivation of the p16INK4a gene.

UR - http://www.scopus.com/inward/record.url?scp=0242643600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242643600&partnerID=8YFLogxK

U2 - 10.1002/path.1419

DO - 10.1002/path.1419

M3 - Article

C2 - 14595762

AN - SCOPUS:0242643600

VL - 201

SP - 487

EP - 495

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -